Semaglutide (Wegovy) for the treatment of obesity or weight management should not be used during pregnancy because weight loss offers no potential benefit to a pregnant woman and may result in fetal harm due to the potential hazard of maternal weight loss to the fetus
Interaction Uncertainty : Potential interactions with medications or underlying conditions remain unknown due to the absence of controlled human studies
Back O'Rahilly, S (15 April 2020' 'The islet's bridesmaid becomes the bride: Proglucagon-derived peptides deliver transformative therapies', Cell , 184, 1945-48
Use the included brush for smooth, mess-free application
Having had pancreatitis in the past doesnt automatically rule out treatment, but your prescriber will weigh the risks more carefully before starting and will ask you to watch for warning signs (severe upper-abdominal pain that spreads to the back, with nausea or vomiting)
Inyectar BAC lentamente sobre la pared lateral del vial